N-(4-Ethoxyphenyl)-2-((1-(2-methylbenzyl)-1H-indol-3-yl)sulfonyl)acetamide

Catalog No. :
ACQTWW810
CAS No. :
850932-85-3
Molecular Formula :
C26H26N2O4S
Molecular Weight :
462.57

IUPAC Name:N-(4-ethoxyphenyl)-2-((1-(2-methylbenzyl)-1H-indol-3-yl)sulfonyl)acetamide

N-(4-Ethoxyphenyl)-2-((1-(2-methylbenzyl)-1H-indol-3-yl)sulfonyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Ethoxyphenyl)-2-((1-(2-methylbenzyl)-1H-indol-3-yl)sulfonyl)acetamide
IUPAC NameN-(4-ethoxyphenyl)-2-((1-(2-methylbenzyl)-1H-indol-3-yl)sulfonyl)acetamide
Molecular FormulaC26H26N2O4S
Molecular Weight462.57
SMILESO=C(NC1=CC=C(OCC)C=C1)CS(=O)(C2=CN(CC3=CC=CC=C3C)C4=C2C=CC=C4)=O
InChI KeyXHRADYDKUNJDGE-UHFFFAOYSA-N
SynonymN-(4-ethoxyphenyl)-2-((1-(2-methylbenzyl)-1H-indol-3-yl)sulfonyl)acetamide;Acetamide, N-(4-ethoxyphenyl)-2-[[1-[(2-methylphenyl)methyl]-1H-indol-3-yl]sulfonyl]-
CAS No.850932-85-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQTWW810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSZPC617 route compound structure diagram
    ACSZPC617637-56-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQTWW810 route product structure diagram
    ACQTWW810850932-85-3
Inquiry

2. ACQTWW810 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQTWW810 route product structure diagram
    ACQTWW810850932-85-3
Inquiry

Comments (0)